This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2MJ Stampfer , FB Hu , JE Manson , . (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343, 16–22.
3PM Kris-Etherton , TD Etherton , J Carlson , . (2002) Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease. Curr Opin Lipidol 13, 397–407.
9JW Anderson (2000) Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. Curr Atheroscler Rep 2, 536–541.
11G Frost , AA Leeds , CJ Doré , . (1999) Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet 353, 1045–1048.
12JW Anderson , KM Randles , CW Kendall , . (2004) Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 23, 5–17.
13I Shai , D Schwarzfuchs , Y Henkin , . (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359, 229–241.
14D Jenkins , C Kendall , G McKeown-Eyssen , . (2008) Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 300, 2742–2753.
15A Erkkilä & A Lichtenstein (2006) Fiber and cardiovascular disease risk: how strong is the evidence? J Cardiovasc Nurs 21, 3–8.
16RS Hall , SK Johnson , AL Baxter , . (2005) Lupin kernel fibre-enriched foods beneficially modify serum lipids in men. Eur J Clin Nutr 59, 325–333.
19JW Anderson , N Zettwoch , T Feldman , . (1988) Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 148, 292–296.
21CM Ripsin , JM Keenan , DRJ Jacobs , . (1992) Oat products and lipid lowering. A meta-analysis. JAMA 267, 3317–3325.
26MH Davidson , LD Dugan , JH Burns , . (1991) The hypocholesterolemic effects of β-glucan in oatmeal and oat bran. A dose-controlled study. JAMA 265, 1833–1839.
34RE Amori , J Lau & AG Pittas (2007) Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 298, 194–206.
35CA Daubioul , Y Horsmans , P Lambert , . (2005) Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59, 723–726.
36M Misikangas , A Pajari , E Päivärinta , . (2005) Promotion of adenoma growth by dietary inulin is associated with increase in cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa. J Nutr Biochem 16, 402–409.
37P Bjerregaard & J Dyerberg (1988) Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol 17, 514–519.
39F Visioli , P Risé , MC Barassi , . (2003) Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids 38, 415–418.
40EO Elvevoll , H Barstad , ES Breimo , . (2006) Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 41, 1109–1114.
41H León , M Shibata , S Sivakumaran , . (2008) Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337, a2931.
42AH Lichtenstein , LJ Appel & M Brands (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
44KC Maki , ME Van Elswyk , D McCarthy , . (2005) Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr 24, 189–199.
46H Bays (2006) Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 98, 71i–76i.
47P Kris-Etherton & A Hill (2008) n-3 Fatty acids: food or supplements? J Am Diet Assoc 108, 1125–1130.
48CR Sirtori & C Galli (2002) n-3 Fatty acids and diabetes. Biomed Pharmacother 56, 397–406.
50CR Sirtori , G Crepaldi , E Manzato , . (1998) One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 137, 419–427.
51P Dubey & SK Cheema (2006) Molecular mechanisms involved in the regulation of lipid and lipoprotein metabolism by fish oil. Fut Lipidol 1, 559–568.
52AD Mooradian , MJ Haas & NC Wong (2006) The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev 27, 2–16.
53C Borghi & A Cicero (2006) Recent evidence of the role of omega-3 polyunsaturated fatty acids on blood pressure control and hypertension-related complications. Fut Lipidol 1, 569–577.
54M Yokoyama , H Origasa , M Matsuzaki , . (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
55F Visioli , P Risè , E Plasmati , . (2000) Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 41, 571–576.
56JJ Carrero , L Baró , J Fonollá , . (2004) Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition 20, 521–527.
57D Mozaffarian & EB Rimm (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885–1899.
58F Marangoni , C Colombo , A Martiello , . (2007) Levels of the n-3 fatty acid eicosapentaenoic acid in addition to those of α linolenic acid are significantly raised in blood lipids by the intake of four walnuts a day in humans. Nutr Metab Cardiovasc Dis 17, 457–461.
59G Burdge (2004) α-Linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137–144.
60C von Schacky (2003) The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 5, 139–145.
61L Djoussé , DK Arnett , JJ Carr , . (2005) Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 111, 2921–2926.
63LS Rallidis , G Paschos , ML Papaioannou , . (2004) The effect of diet enriched with α-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 174, 127–132.
65E Wendland , A Farmer , P Glasziou , . (2006) Effect of α linolenic acid on cardiovascular risk markers: a systematic review. Heart 92, 166–169.
66WS Harris (2005) α-Linolenic acid: a gift from the land? Circulation 111, 2872–2874.
67HRJ Davis , LJ Zhu , LM Hoos , . (2004) Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279, 33586–33592.
68FJ Field , E Born & SN Mathur (2004) Stanol esters decrease plasma cholesterol independently of intestinal ABC sterol transporters and Niemann-Pick C1-like 1 protein gene expression. J Lipid Res 45, 2252–2259.
69TA Miettinen , P Puska , H Gylling , . (1995) Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333, 1308–1312.
70H Gylling , R Radhakrishnan & TA Miettinen (1997) Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 96, 4226–4231.
72MH Davidson , KC Maki , DM Umporowicz , . (2001) Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr 20, 307–319.
74HA Neil , GW Meijer & LS Roe (2001) Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156, 329–337.
75FY Ntanios & GS Duchateau (2002) A healthy diet rich in carotenoids is effective in maintaining normal blood carotenoid levels during the daily use of plant sterol-enriched spreads. Int J Vitam Nutr Res 72, 32–39.
78NB Cater , AB Garcia-Garcia , GL Vega , . (2005) Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol 96, 23D–28D.
79FH O'Neill , A Brynes , R Mandeno , . (2004) Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis 14, 133–142.
82CA Spilburg , AC Goldberg , JB McGill , . (2003) Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. J Am Diet Assoc 103, 577–581.
83P Salo & I Wester (2005) Low-fat formulations of plant stanols and sterols. Am J Cardiol 96, 51D–54D.
84P Clifton (2002) Plant sterol and stanols – comparison and contrasts Sterols versus stanols in cholesterol-lowering: is there a difference? Atheroscler Suppl 3, 5–9.
87I Demonty , R Ras , H van der Knaap , . (2009) Continuous dose–response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 139, 271–284.
88SS AbuMweis , R Barake & P Jones (2008) Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 52 .
89S de Jongh , MN Vissers , P Rol , . (2003) Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 26, 343–351.
90Anonymous (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
91M Wolfs , N de Jong , MC Ocké , . (2006) Effectiveness of customary use of phytosterol/stanol-enriched margarines on blood cholesterol lowering. Food Chem Toxicol 44, 1682–1688.
96AM Coates & PR Howe (2007) Edible nuts and metabolic health. Curr Opin Lipidol 18, 25–30.
97PM Kris-Etherton , G Zhao , AE Binkoski , . (2001) The effects of nuts on coronary heart disease risk. Nutr Rev 59, 103–111.
99CM Albert , JM Gaziano , WC Willett , . (2002) Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med 162, 1382–1387.
101C Alasalvar , F Shahidi & KR Cadwallader (2003) Comparison of natural and roasted Turkish tombul hazelnut (Corylus avellana L.) volatiles and flavor by DHA/GC/MS and descriptive sensory analysis. J Agric Food Chem 51, 5067–5072.
102SM Mercanligil , P Arslan , C Alasalvar , . (2007) Effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men. Eur J Clin Nutr 61, 212–220.
103AR Josse , CW Kendall , LS Augustin , . (2007) Almonds and postprandial glycemia – a dose–response study. Metabolism 56, 400–404.
107DN Kim , KT Lee , JM Reiner , . (1980) Increased steroid excretion in swine fed high-fat, high-cholesterol diet with soy protein. Exp Mol Pathol 33, 25–35.
111A Gaddi , GC Descovich , G Noseda , . (1987) Hypercholesterolaemia treated by soybean protein diet. Arch Dis Child 62, 274–278.
114J Burslem , G Schonfeld , MA Howald , . (1978) Plasma apoprotein and lipoprotein lipid levels in vegetarians. Metabolism 27, 711–719.
117TL Halton , WC Willett , S Liu , . (2006) Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med 355, 1991–2002.
118JW Anderson , BM Johnstone & ME Cook-Newell (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276–282.
119FM Sacks , A Lichtenstein , L Van Horn , . (2006) Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034–1044.
122J Harland & T Haffner (2008) Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200, 13–27.
126MR Lovati , C Manzoni , A Canavesi , . (1987) Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80, 1498–1502.
130CR Sirtori , A Arnoldi & SK Johnson (2005) Phytoestrogens: end of a tale? Ann Med 37, 423–438.
136MF Wang , S Yamamoto , HM Chung , . (1995) Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J Nutr Sci Vitaminol (Tokyo) 41, 187–195.
137G Hori , MF Wang , YC Chan , . (2001) Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers. Biosci Biotechnol Biochem 65, 72–78.
138S Cho , M Juillerat & C Lee (2008) Identification of LDL-receptor transcription stimulating peptides from soybean hydrolysate in human hepatocytes. J Agric Food Chem 56, 4372–4376.
139P Deibert , D König , A Schmidt-Trucksaess , . (2004) Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord 28, 1349–1352.
140M Kohno , M Hirotsuka , M Kito , . (2006) Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean β-conglycinin. J Atheroscler Thromb 13, 247–255.
142L Azadbakht , M Kimiagar , Y Mehrabi , . (2007) Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 30, 967–973.
143JM Martins , M Riottot , MC de Abreu , . (2005) Cholesterol-lowering effects of dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs. J Lipid Res 46, 1539–1547.
145J Spielmann , A Shukla , C Brandsch , . (2007) Dietary lupin protein lowers triglyceride concentrations in liver and plasma in rats by reducing hepatic gene expression of sterol regulatory element-binding protein-1c. Ann Nutr Metab 51, 387–392.
147G Chiesa , C Di Mario , N Colombo , . (2001) Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 156, 277–287.
149G Nowicka , L Klosiewicz-Latoszek , CR Sirtori , . (2006) Lupin proteins in the treatment of hypercholesterolemia. Atheroscler Suppl 7, 477.
150Y Lee , T Mori , I Puddey , . (2009) Effects of lupin kernel flour-enriched bread on blood pressure: a controlled intervention study. Am J Clin Nutr 89, 766–772.
151JB Lasekan , L Gueth & S Khan (1995) Influence of dietary golden pea protein versus casein on plasma and hepatic lipids in rats. Nutr Res 15, 71–84.
152R Alonso , G Grant & F Marzo (2001) Thermal treatment improves nutritional quality of pea seeds (Pisum sativum L.) without reducing their hypocholesterolemic properties. Nutr Res 21, 1067–1077.
153MA Zulet , MT Macarulla , MP Portillo , . (1999) Lipid and glucose utilization in hypercholesterolemic rats fed a diet containing heated chickpea (Cicer aretinum L.): a potential functional food. Int J Vitam Nutr Res 69, 403–411.
161W Oosthuizen , CS Scholtz , HH Vorster , . (2000) Extruded dry beans and serum lipoprotein and plasma haemostatic factors in hyperlipidaemic men. Eur J Clin Nutr 54, 373–379.
165DM Winham & AM Hutchins (2007) Aked bean consumption reduces serum cholesterol in hypercholesterolemic adults. Nutr Res 27, 380–386.
169C Sirtori , C Galli , J Anderson , . (2009) Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis 203, 8–17.
170L Vercruysse , J Van Camp & G Smagghe (2005) ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. J Agric Food Chem 53, 8106–8115.
171EL Ding , SM Hutfless , X Ding , . (2006) Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond) 3, 2.
172T Kurosawa , F Itoh , A Nozaki , . (2005) Suppressive effect of cocoa powder on atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. J Atheroscler Thromb 12, 20–28.
173D Grassi , S Necozione , C Lippi , . (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398–405.
174H Schroeter , C Heiss , J Balzer , . (2006) ( − )-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024–1029.
178SP Zhao , L Liu , YC Cheng , . (2004) Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation 110, 915–920.
180JK Keithley , B Swanson , BE Sha , . (2002) A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition 18, 201–204.
181S Zhao , Z Lu , B Du , . (2007) Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China Coronary Secondary Prevention Study (CCSPS). J Cardiovasc Pharm 49, 81–84.
182D Becker , R Gordon , S Halbert , . (2009) Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 150, 830–839.
183PO Szapary , ML Wolfe , LT Bloedon , . (2003) Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 290, 765–772.
184RB Singh , MA Niaz & S Ghosh (1994) Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 8, 659–664.
187T Ishikawa , Y Fujiyama , O Igarashi , . (1989) Effects of γ-linolenic acid on plasma lipoproteins and apolipoproteins. Atherosclerosis 75, 95–104.
188M Boberg , B Vessby & I Selinus (1986) Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Med Scand 220, 153–160.
191RA Anderson , CL Broadhurst , MM Polansky , . (2004) Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52, 65–70.
192A Khan , M Safdar , MM Ali Khan , . (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26, 3215–3218.
193BG Brown , MC Cheung , AC Lee , . (2002) Antioxidant vitamins and lipid therapy: end of a long romance? Arterioscler Thromb Vasc Biol 22, 1535–1546.
195S Baliarsingh , ZH Beg & J Ahmad (2005) The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 182, 367–374.
196BL Song & RA DeBose-Boyd (2006) Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ- and γ-tocotrienols. J Biol Chem 281, 25054–25061.
200C Stevinson , MH Pittler & E Ernst (2000) Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 133, 420–429.
203RT Ackermann , CD Mulrow , G Ramirez , . (2001) Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 161, 813–824.
204CD Gardner , LD Lawson , E Block , . (2007) Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 167, 346–353.
209S Bidel , G Hu , Q Qiao , P Jousilahti , . (2006) Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 49, 2618–2626.
210Y Miyake , S Kono , M Nishiwaki , . (1999) Relationship of coffee consumption with serum lipids and lipoproteins in Japanese men. Ann Epidemiol 9, 121–126.
211E Strandhagen & DS Thelle (2003) Filtered coffee raises serum cholesterol: results from a controlled study. Eur J Clin Nutr 57, 1164–1168.
212MC Cornelis & A El-Sohemy (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care 10, 745–751.
213MC Cornelis , A El-Sohemy , EK Kabagambe , . (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295, 1135–1141.
214BE Sumpio , AC Cordova , DW Berke-Schlessel , . (2006) Green tea, the ‘Asian paradox,’ and cardiovascular disease. J Am Coll Surg 202, 813–825.
215R Cooper , DJ Morré & DM Morré (2005) Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med 11, 521–528.
216S Kuriyama , T Shimazu , K Ohmori , . (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296, 1255–1265.
217U Peters , C Poole & I Arab (2001) Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 154, 495–503.
219DL McKay & JB Blumberg (2002) The role of tea in human health: an update. J Am Coll Nutr 21, 1–13.
221T Nagao , S Meguro , T Hase , . (2009) A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 17, 310–317.
223I Gouni-Berthold & HK Berthold (2002) Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 143, 356–365.
224HK Berthold , S Unverdorben , R Degenhardt , . (2006) Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 295, 2262–2269.
226F Francini-Pesenti , F Brocadello , D Beltramolli , . (2008) Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study. Complement Ther Med 16, 61–65.
227A Kassis & P Jones (2008) Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial. Lipids Health Dis 7, 17.
230MI Uusitupa , E Ruuskanen , E Makinen , . (1992) A controlled study on the effect of β-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 11, 651–659.
231AL Amundsen , B Haugum & H Andersson (2003) Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand J Nutr 47, 68–74.
234G Onning , A Wallmark , M Persson , . (1999) Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 43, 301–309.
238L Van Horn , A Moag-Stahlberg , K Liu , . (1991) Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 81, 183–188.
239K Queenan , M Stewart , K Smith , . (2007) Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6, 6.
241N Reyna-Villasmil , V Bermúdez-Pirela , E Mengual-Moreno , . (2007) Oat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14, 203–212.
247M Hallikainen , E Sarkkinen , H Gylling , . (2000) Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54, 715–725.
249M Mussner , K Parhofer , K Von Bergmann , . (2002) Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 51, 189–194.